reports
Sensei Biotherapeutics Reports First Quarter 2024 Financial Results an...
Sensei Biotherapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights - Completed SNS-101 monotherapy and combination dose escalation through 15mg/kg with no dose limiting toxicities - - Company to present topline clinical data from the SNS-101 Phase 1 dose escalation study at the 2024 ASCO Annual Meeting - - Enrollment in the dose expansion portion of the clinical study advancing - - Strong balance sheet with cash runway into fourth quarter of 2025 - BOSTON, May 09, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage imm...
Capital Bank Welcomes Jim Witty as Senior Vice President - Director of...
Capital Bank Welcomes Jim Witty as Senior Vice President - Director of Contractor Banking ROCKVILLE, Md., May 07, 2024 (GLOBE NEWSWIRE) -- Capital Bank (NASDAQ: CBNK), a prominent financial institution serving the DC Metro area, is proud to announce the appointment of Jim Witty as Senior Vice President - Director of Contractor Banking. With a commercial banking career spanning over 30 years, many spent in leadership roles, Jim has a strong track record of helping businesses grow, driving strategic objectives, and fostering long-lasting relationships with his clients. "We are excited ...
- Jonathan Moreland
RF REGIONS FINANCIAL CORPORATION
NEOG NEOGEN CORPORATION
LGND LIGAND PHARMACEUTICALS INCORPORATED
INTC INTEL CORPORATION
HXL HEXCEL CORPORATION
FFIN FIRST FINANCIAL BANKSHARES INC
EGBN EAGLE BANCORP INC.
DLTR DOLLAR TREE INC.
CINF CINCINNATI FINANCIAL CORPORATION
CHDN CHURCHILL DOWNS INCORPORATED
SWKS SKYWORKS SOLUTIONS INC.
HTLD HEARTLAND EXPRESS INC.
ZUMZ ZUMIEZ INC.
TRT TRIO TECH INTERNATIONAL
CET CENTRAL SECURITIES CORP.
LIND LINDBLAD EXPEDITIONS HOLDINGS
WDFC WD-40 COMPANY
FEIM FREQUENCY ELECTRONICS INC.
AINC ASHFORD
CLF CLIFFS NATURAL RESOURCES INC.
PWOD PENNS WOODS BANCORP INC.
ATOM ATOMERA
LOVE LOVESAC
FVCB FVCBANKCORP
INMB INMUNE BIO
MCFT INC.
CAPR MASTERCRAFT BOAT HOLDINGS
RYES CAPRICOR THERAPEUTICS
HQL PATRIOT MINEFINDERS INC.
SOWG TEKLA LIFE SCIENCES INVESTORS
CPZ SOW GOOD INC.
AUID CALAMOS LONG/SHORT EQUITY AND DYNAMIC INCOME TRUST
JBHT IPSIDY INC.
TBBK J.B. HUNT TRANSPORT SERVICES
MPA INC.
FTHY THE BANCORP
AIKI INC.
BHVN BLACKROCK MUNIYIELD PENNSYLVANIA FD
BUKS FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND
ACRV AIKIDO PHARMA INC.
ZURA BIOHAVEN LTD
ABEO BUTLER NATIONAL CORP
STCN ACRIVON THERAPEUTICS INC
KRRO ZURA BIO LTD
LSXMA ABEONA THERAPEUTICS INC.
EP STEEL CONNECT INC
INTZ KORRO BIO INC
LGVN LIBERTY SIRIUSXM GROUP
OCX EMPIRE PETROLEUM CORP
EYPT INTRUSION INC
IZEA LONGEVERON INC
CFFI ONCOCYTE CORPORATION
EYEPOINT PHARMACEUTICALS
INC.
IZEA WORLDWIDE INC
C&F FINANCIAL CORPORATION
- Jonathan Moreland
SPWR SUNPOWER CORPORATION
NQP NUVEEN PENNSYLVANIA INVESTMENT QUALITY MUNICIPAL FUND INC.
NXJ NUVEEN NEW JERSEY DIVIDEND ADVANTAGE MUNICIPAL FUND
MHI PIONEER MUNICIPAL HIGH INCOME TRUST
FRAF FRANKLIN FINANCIAL SERVICES CO.
ZM ZOOM VIDEO COMMUNICATIONS
MRBK INC.
RYES MERIDIAN
LUMN PATRIOT MINEFINDERS INC.
VPV LUMEN TECHNOLOGIES INC.
MEGI INVESCO PA VALUE MUNI INC TST
IZEA MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
IZEA WORLDWIDE INC
Capital Bank Welcomes Todd Warren as Market Executive for the Greater ...
Capital Bank Welcomes Todd Warren as Market Executive for the Greater Chesapeake and Baltimore Regions ROCKVILLE, Md., May 01, 2024 (GLOBE NEWSWIRE) -- Capital Bank (NASDAQ: CBNK) is pleased to announce the appointment of Todd Warren as Senior Vice President and Market Executive for the Greater Chesapeake and Baltimore regions. With over 26 years in banking, Mr. Warren brings invaluable expertise and insights to the bank. Mr. Warren will play a key role in Capital Bank’s C&I growth strategy by leading two C&I teams in Baltimore and Columbia, MD. "Todd's extensive industry knowledge and d...
- Jonathan Moreland
MSCI MSCI INC. CLASS A
LGND LIGAND PHARMACEUTICALS INCORPORATED
CTRN CITI TRENDS INC.
BANC BANC OF CALIFORNIA INCORPORATED
LIND LINDBLAD EXPEDITIONS HOLDINGS
NQP NUVEEN PENNSYLVANIA INVESTMENT QUALITY MUNICIPAL FUND INC.
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
BRT BRT APARTMENTS
LOVE LOVESAC
FVCB FVCBANKCORP
HROW HARROW HEALTH INC.
INMB INMUNE BIO
MCFT INC.
CAPR MASTERCRAFT BOAT HOLDINGS
HQL CAPRICOR THERAPEUTICS
AUID TEKLA LIFE SCIENCES INVESTORS
BHVN IPSIDY INC.
MAIA BIOHAVEN LTD
MEGI MAIA BIOTECHNOLOGY INC
NPCT MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
RXO_w NUVEEN CORE PLUS IMPACT FD
ZURA RXO INC
ABEO ZURA BIO LTD
STCN ABEONA THERAPEUTICS INC.
KRRO STEEL CONNECT INC
EP KORRO BIO INC
ASGI EMPIRE PETROLEUM CORP
INTZ ABERDEEN STANDARD GLOBAL INFRASTRUCTURE INCOME FUND
EYPT INTRUSION INC
IZEA EYEPOINT PHARMACEUTICALS
INC.
IZEA WORLDWIDE INC
- Jonathan Moreland
Sensei Biotherapeutics to Present Topline Clinical Data from the SNS-1...
Sensei Biotherapeutics to Present Topline Clinical Data from the SNS-101 Phase I Dose Escalation Study at the 2024 ASCO Annual Meeting BOSTON, April 24, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that topline clinical data from the monotherapy and combination dose escalation portion of its Phase 1/2 trial of SNS-101, a conditionally active, human monoclonal antibody targeting the immune checkpoint VISTA (V-domain ...
- Jonathan Moreland
Capital Bancorp, Inc. Reports First Quarter 2024 Results
Capital Bancorp, Inc. Reports First Quarter 2024 Results Net Income of $6.6 million, or $0.47 per share. Net Income, as adjusted(1) of $7.1 million, or $0.51 per shareROAA of 1.15% and ROAE of 10.19% for 1Q 2024Adjusted Metrics(1) excluding Merger-Related Expenses: ROAA of 1.24% and ROAE of 11.03% for 1Q 2024 Loan Growth of $61.2 million, or 12.9% annualized for 1Q 2024Deposit Growth of $109.7 million; Noninterest bearing deposits increased $48.4 million, or 7.8% from 4Q 2023Cash dividend of $0.08 per share declared ROCKVILLE, Md., April 22, 2024 (GLOBE NEWSWIRE) -- Capital Bancorp, Inc....
- Jonathan Moreland
- Jonathan Moreland
- Jonathan Moreland
Sensei Biotherapeutics to Participate in Canaccord Genuity’s Horizons ...
Sensei Biotherapeutics to Participate in Canaccord Genuity’s Horizons in Oncology Virtual Conference BOSTON, April 09, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), an immuno-oncology company focused on the discovery and development of next generation therapeutics for cancer patients, today announced that Company management will participate in a panel titled ‘KRAS and VISTA - Better Approaches for Key Targets’ at Canaccord Genuity’s Horizons in Oncology Virtual Conference on Monday, April 15th at 2:00 p.m. ET. The panel will feature Dr. Shiraj Sen, M.D., Ph.D., M...
- Jonathan Moreland
BRT BRT APARTMENTS
FPF FIRST TRUST INTERMEDIATE DURATION PREFERRED AND INCOME FUND
ZM ZOOM VIDEO COMMUNICATIONS
EGLE INC.
MPA EAGLE BULK SHIPPING
BUKS BLACKROCK MUNIYIELD PENNSYLVANIA FD
NPCT BUTLER NATIONAL CORP
ASGI NUVEEN CORE PLUS IMPACT FD
ABERDEEN STANDARD GLOBAL INFRASTRUCTURE INCOME FUND
Capital Bank Welcomes Anguel Lindarev as Chief Information Officer
Capital Bank Welcomes Anguel Lindarev as Chief Information Officer ROCKVILLE, Md., April 05, 2024 (GLOBE NEWSWIRE) -- Capital Bank (NASDAQ: CBNK), a leading commercial bank in the DC Metro Region, is pleased to announce the appointment of Anguel Lindarev as Executive Vice President and Chief Information Officer (CIO), effective immediately. With more than 25 years of experience in leading technology and innovation strategies, Mr. Lindarev brings a wealth of knowledge and expertise to Capital Bank's executive team. As CIO, Mr. Lindarev will partner with Capital Bank's CEO, Executive Manag...
Sensei Biotherapeutics Announces Nature Communications Publication Des...
Sensei Biotherapeutics Announces Nature Communications Publication Describing Mechanism of Action of SNS-101 Selectively Targeting the Active Form of VISTA within the Tumor Microenvironment BOSTON, April 04, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced the publication of a peer-reviewed research paper in Nature Communications. The research was conducted by scientists at Sensei Biotherapeutics in collaboration with g...
- Jonathan Moreland
NXJ NUVEEN NEW JERSEY DIVIDEND ADVANTAGE MUNICIPAL FUND
BRT BRT APARTMENTS
FMN FEDERATED PREMIER MUNICIPAL INCOME FUND
ZM ZOOM VIDEO COMMUNICATIONS
BFZ INC.
MPA BLACKROCK CALIF MUN INCOME TRUST
AMPX BLACKROCK MUNIYIELD PENNSYLVANIA FD
BIGZ AMPRIUS TECHNOLOGIES INC
ECAT BLACKROCK INNOVATION AND GROWTH TST
NPCT BLACKROCK ESG CAP ALLOCATION TR
ELVN NUVEEN CORE PLUS IMPACT FD
BMEZ IMARA INC
ASGI BLACKROCK HEALTH SCIENCES TERM TRUST
ABERDEEN STANDARD GLOBAL INFRASTRUCTURE INCOME FUND
Capital Bancorp, Inc. Announces Acquisition of Integrated Financial Ho...
Capital Bancorp, Inc. Announces Acquisition of Integrated Financial Holdings, Inc. Further Diversifies CBNK with a Niche C&I Business that is Capital Efficient, High-Return and Generates Meaningful Fee Income ROCKVILLE, Md., March 28, 2024 (GLOBE NEWSWIRE) -- Capital Bancorp, Inc. ("CBNK” or “Capital") (NASDAQ: CBNK) and Integrated Financial Holdings, Inc. (“IFH”) (OTCQX: IFHI) today announced that they have entered into a definitive merger agreement under which CBNK will acquire IFH in a cash and stock transaction valued at $66 million, exclusive of the value of a dividend to be receiv...
Sensei Biotherapeutics to Participate in the 3rd Annual VISTA Symposiu...
Sensei Biotherapeutics to Participate in the 3rd Annual VISTA Symposium BOSTON, March 22, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (NASDAQ: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next generation therapeutics for cancer patients, today announced that Company management will participate on a panel titled ‘Anti-VISTA Immunotherapies in Clinical Development’ at the 3rd Annual VISTA Symposium. The VISTA Symposium will convene scientific experts and industry leaders to explore the important emerging role of VISTA in cancer immuno...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.